TODD GOLUB, M.D.
Director and Founding Core Institute Member, Broad Institute of MIT and Harvard
Professor, Harvard Medical School
Charles A. Dana Investigator in Human Cancer Genetics, Dana-Farber Cancer Institute

TODD GOLUB is the director and a founding core institute member of the Broad Institute of MIT and Harvard. He is also a professor at Harvard Medical School and the Charles A. Dana investigator in human cancer genetics at the Dana-Farber Cancer Institute. Golub is one of the first researchers to use genomic approaches to molecularly characterize human tumors, laying the foundation for the use of genomics to classify, diagnose, and treat cancer. Early in his career as a pediatric oncologist and cancer researcher, Golub made key discoveries on the genetic and molecular origins of the most common form of childhood leukemia, acute lymphoblastic leukemia. These fundamental insights led to changes in treatment that are now the standard of care.

Golub helped launch the Broad Institute in 2004 and served as director of the Cancer Program for 17 years. In addition, Golub was the Broad’s chief scientific officer for a decade before being named director in January 2021. Golub is the recipient of multiple awards, including the Outstanding Achievement Award from the American Association for Cancer Research and the Judson Daland Prize from the American Philosophical Society. Golub is also an elected member of both the National Academy of Medicine and the National Academy of Sciences.

Photo courtesy of Broad Institute of MIT and Harvard